Bridgeway Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Sell |
37,800
-400
| -1% | -$18.5K | 0.04% | 550 |
|
|
2025
Q1 | $2.33M | Buy |
+38,200
| New | +$2.33M | 0.06% | 451 |
|
|
2024
Q4 | – | Sell |
-29,700
| Closed | -$1.54M | – | 1212 |
|
|
2024
Q3 | $1.54M | Sell |
29,700
-2,179
| -7% | -$113K | 0.03% | 574 |
|
|
2024
Q2 | $1.32M | Buy |
+31,879
| New | +$1.32M | 0.03% | 611 |
|
|
2022
Q4 | – | Sell |
-150,379
| Closed | -$10.7M | – | 1380 |
|
|
2022
Q3 | $10.7M | Sell |
150,379
-86,800
| -37% | -$6.17M | 0.29% | 65 |
|
|
2022
Q2 | $18.3M | Sell |
237,179
-32,300
| -12% | -$2.49M | 0.42% | 17 |
|
|
2022
Q1 | $19.7M | Sell |
269,479
-24,850
| -8% | -$1.81M | 0.38% | 26 |
|
|
2021
Q4 | $18.4M | Buy |
294,329
+8,800
| +3% | +$549K | 0.34% | 45 |
|
|
2021
Q3 | $16.9M | Sell |
285,529
-31,700
| -10% | -$1.88M | 0.32% | 55 |
|
|
2021
Q2 | $21.2M | Sell |
317,229
-2,325
| -0.7% | -$155K | 0.38% | 46 |
|
|
2021
Q1 | $20.2M | Buy |
319,554
+97,125
| +44% | +$6.13M | 0.38% | 50 |
|
|
2020
Q4 | $13.8M | Sell |
222,429
-194,800
| -47% | -$12.1M | 0.29% | 101 |
|
|
2020
Q3 | $25.2M | Buy |
+417,229
| New | +$25.2M | 0.58% | 28 |
|
|
2016
Q4 | – | Sell |
-3,879
| Closed | -$209K | – | 1409 |
|
|
2016
Q3 | $209K | Hold |
3,879
| – | – | ﹤0.01% | 1311 |
|
|
2016
Q2 | $285K | Hold |
3,879
| – | – | ﹤0.01% | 1228 |
|
|
2016
Q1 | $248K | Buy |
+3,879
| New | +$248K | ﹤0.01% | 1260 |
|